Tracon Pharmaceuticals Inc. (TCON)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Ikarian Capital

Neil Shahrestani

2,691,110 $10,415 -1% 0.73%
2.
Opaleye Management

James A. Silverman

2,518,371 $9,746 1.82%
3.
Two Sigma Advisors

John Overdeck And David Siegel

367,800 $1,423 +30% 0%
4. 306,976 $1,188 +77% 0%
5.
Millennium Management

Israel Englander

139,477 $540 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.82 3,500 Officer, Director 219,318 2021-11-19 Filing
$2.88 681 Officer, Director 215,818 2021-11-18 Filing
$3.42 3,000 Officer, Director 215,137 2021-11-05 Filing
$3.41 1,000 Officer, Director 212,137 2021-11-05 Filing
$3.56 3,000 Officer, Director 207,732 2021-08-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.92 340,134 Large Shareholder 76,048 2019-12-09 Filing
$3.05 43,996 Large Shareholder 416,182 2019-12-05 Filing
$1.21 4,326 Large Shareholder 4,601,768 2018-11-29 Filing
$1.21 4,326 Large Shareholder 4,601,768 2018-11-29 Filing
$2.69 2,500 Director 13,388 2017-06-02 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 785,341 $3,039 0.79%
2. 694,859 $2,689 0%
3. 346,718 $1,342 0.01%
4. 319,775 $1,238 0%
5. 299,283 $1,159 0%
News See All